IP Library Granted Patent US 11,890,180
Granted Patent B2
US 11,890,180 · App. 18/359,370 · Granted Feb 6, 2024

System for treating embolism and associated devices and methods

Inventors: Ben Merritt (San Clemente, CA); Jacqueline Macias (Fullerton, CA); Brian Michael Strauss (San Clemente, CA); Thomas Tu (Louisville, KY)
Assignee: Inari Medical, Inc.
A61F2/01A61B17/12109A61M1/815A61M1/84A61B17/221A61B2017/22034A61B2017/22079A61B2217/005A61M1/79A61M25/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,890,180
App. No.
18/359,370
Filed
Jul 26, 2023
Granted
Feb 6, 2024
Kind
B2
Art Unit
3781
USPC
606/127
Abstract

Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a distal portion of a catheter proximate to the clot material within the blood vessel. The method can further include coupling a pressure source to the catheter via a tubing subsystem including a valve or other fluid control device and, while the valve is closed, activating the pressure source to charge a vacuum. The valve can then be opened to apply the vacuum to the catheter to thereby aspirate at least a portion of the clot material from the blood vessel and into the catheter.

Claims (38)

1. A method for the treatment of clot material within a vasculature of a patient, the method comprising:

positioning a catheter at least partially within the vasculature proximate to the clot material, wherein the catheter is configured to be fluidically coupled to a pressure source via a fluid control device, and wherein (a) opening of the fluid control device fluidically connects the pressure source to the catheter and (b) closing of the fluid control device fluidically disconnects the pressure source from the catheter;

with the fluid control device closed to inhibit fluid flow from the catheter to the pressure source, activating the pressure source to generate negative pressure within the pressure source; and

after generating the negative pressure, opening the fluid control device to apply the negative pressure to the catheter to generate a flow rate within the catheter of greater than about 60 cubic centimeters per second to thereby aspirate at least a portion of the clot material into the catheter.

2. The method of claim 1 wherein the catheter has a size of 16 French.

3. The method of claim 1 wherein the pressure source has a volume of about 60 cubic centimeters or less.

4. The method of claim 1 wherein the pressure source has a volume of about 60 cubic centimeters or greater.

5. The method of claim 1 wherein the flow rate is greater than about 100 cubic centimeters per second.

6. The method of claim 5 wherein the catheter has a size of 20 French.

7. The method of claim 5 wherein the pressure source has a volume of about 60 cubic centimeters or less.

8. The method of claim 5 wherein the pressure source has a volume of about 60 cubic centimeters or greater.

9. The method of claim 1 wherein the flow rate is greater than about 150 cubic centimeters per second.

10. The method of claim 9 wherein the catheter has a size of 24 French.

11. The method of claim 9 wherein the pressure source has a volume of about 60 cubic centimeters or less.

12. The method of claim 11 wherein the pressure source has a volume of about 60 cubic centimeters or greater.

13. The method of claim 1 wherein the pressure source is a syringe.

14. The method of claim 1 wherein the clot material comprises a pulmonary embolism.

15. The method of claim 1 wherein the clot material comprises a deep vein thrombus.

16. The method of claim 1 wherein the method further comprises selectively providing fluid access to a lumen of the catheter via a hemostasis valve fluidically coupled to the lumen of the catheter.

17. The method of claim 1 wherein the method further comprises filtering the clot material from blood via a filter fluidically coupled between the pressure source and the catheter.

18. The method of claim 17 wherein the method further comprises reintroducing the filtered blood into the blood vessel.

19. The method of claim 1 wherein the method further comprises, after opening the fluid control device to apply the negative pressure to the catheter, permitting a pressure differential between the pressure source and the catheter to equalize in less than about 1 second.

20. The method of claim 1 wherein the method further comprises, after opening the fluid control device to apply the negative pressure to the catheter, permitting a pressure differential between the pressure source and the catheter to equalize in less than about 0.6 second.

21. The method of claim 1 wherein the method further comprises, after opening the fluid control device to apply the negative pressure to the catheter, permitting a pressure differential between the pressure source and the catheter to equalize in less than about 0.4 second.

22. A system for the intravascular treatment of clot material from within a vasculature of a patient, the system comprising:

a catheter configured to be positioned at least partially within the vasculature proximate to the clot material;

a pressure source configured to generate negative pressure; and

a fluid control device fluidically coupled between the pressure source and the catheter, wherein—

the fluid control device is configured to be closed to fluidically disconnect the pressure source from the catheter when the pressure source generates the negative pressure; and

the fluid control device is configured to be opened to fluidically connect the pressure to the catheter after the pressure source generates the negative pressure to generate a flow rate within the catheter of greater than about 60 cubic centimeters per second to thereby aspirate at least a portion of the clot material into the catheter.

23. The system of claim 22 wherein the catheter has a size of 16 French.

24. The system of claim 22 wherein the pressure source has a volume of about 60 cubic centimeters or greater.

25. The system of claim 22 wherein the pressure source has a volume of about 60 cubic centimeters or less.

26. The system of claim 22 wherein the flow rate is greater than about 100 cubic centimeters per second.

27. The system of claim 26 wherein the catheter has a size of 20 French.

28. The system of claim 26 wherein the pressure source has a volume of about 60 cubic centimeters or less.

29. The system of claim 22 wherein the flow rate is greater than about 150 cubic centimeters per second.

30. The system of claim 29 wherein the catheter has a size of 24 French.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 29, 2026
From: INARI MEDICAL, INC.
To: STRYKER CORPORATION
Reel/Frame 075486/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2023
From: MERRITT, BEN; MACIAS, JACQUELINE; STRAUSS, BRIAN MICHAEL
To: INARI MEDICAL, INC.
Reel/Frame 064812/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2023
From: TU, THOMAS
To: INARI MEDICAL, INC.
Reel/Frame 064812/0510 →
Continuity (7)
Continuation 18167757 · Feb 10, 2023
Continuation 17976711 · Oct 28, 2022
Continuation 17865315 · Jul 14, 2022
Continuation 16536185 · Aug 8, 2019
Provisional Application 62718248 · Aug 13, 2018
Provisional Application 62718269 · Aug 13, 2018
Related Publication 20230363883A1 · Nov 16, 2023
Cited By (17)
US 12,239,333 US 12,251,120 US 12,274,459 US 12,285,182 US 12,310,608 US 12,343,028 US 12,350,443 US 12,364,496 US 12,414,785 US 12,453,564 US 12,465,382 US 12,496,081 US 12,558,112 US 12,558,486 US 12,685,549 US 12,685,557 US 12,702,538